Dr. Alexander Rubinsteyn (Assistant Professor, Genetics) was awarded a Novocure Career Development Award from the American Association for Cancer Research (AACR) for his project titled “Impact of Tumor Treating Fields on Neoantigen Burden and T Cell Function”.
This project will focus on using tumor treating fields as immune modulator and consolidating their use in the treatment of new and recurrent glioblastoma tumors and potentially other metastases to the brain.